Showing results (171-180 of 935) with videos related to
Sort By:
Pageof 94
Psychopharmacology|January 1, 1988
The pharmacological characterisation of pilocarpine-induced purposeless chewing behaviour in the ratB R Stewart, P Jenner, C D MarsdenNeuropharmacology|June 1, 1989
Behavioural and morphological changes following treatment with GM-1 ganglioside of rats with an electrolytic lesion of the substantia nigraE A Jackson, P Jenner, C D MarsdenPsychopharmacology|January 1, 1989
Assessment of the muscarinic receptor subtype involved in the mediation of pilocarpine-induced purposeless chewing behaviourB R Stewart, P Jenner, C D MarsdenBiochemical Pharmacology|October 15, 1986
Hypophysectomy may non-selectively alter pharmacokinetic parameters to enhance the ability of haloperidol to increase striatal dopamine receptor density in the ratM D Simpson, P Jenner, C D MarsdenBritish Journal of Clinical Pharmacology|January 1, 1977
Nomifensine in Parkinson's diseaseP Bedard, J D Parkes, C D MarsdenThe Journal of Pharmacy and Pharmacology|May 1, 1985
Properties of rat striatal D-2 dopamine receptors solubilized with the zwitterionic detergent CHAPSG J Kilpatrick, P Jenner, C D MarsdenBrain : a Journal of Neurology|April 1, 1992
Simple and choice reaction time and the use of advance information for motor preparation in Parkinson's diseaseM Jahanshahi, R G Brown, C D MarsdenNeurology|December 1, 1992
New insights into the cause of Parkinson's diseaseP Jenner, A H Schapira, C D MarsdenJournal of Neurology, Neurosurgery, and Psychiatry|April 1, 1975
Metoclopramide and pimozide in Parkinson's disease and levodopa-induced dyskinesiasD Tarsy, J D Parkes, C D MarsdenArchives of Neurology|February 1, 1975
Clonidine in Parkinson diseaseD Tarsy, J D Parkes, C D MarsdenPageof 94